Form 4: Schwab Director Carolyn Schwab-Pomerantz Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Carolyn Schwab-Pomerantz sold shares of Schwab (SCHW) common stock on March 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

  • Carolyn Schwab-Pomerantz, a director of Schwab, sold shares of common stock on March 6, 2025.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on August 14, 2024.
  • A total of 14,400 shares were sold at a weighted average price of $75.5823, and 9,600 shares were sold at a weighted average price of $75.5894.
  • The transactions were executed in multiple trades within price ranges of $75.25 to $75.90 and $75.26 to $75.90, respectively.
  • Following the reported transactions, Schwab-Pomerantz beneficially owns 8,162 shares directly, 1,559,993.6599 shares indirectly through a trust, 515,329 shares indirectly through a spouse as trustee, and 2,798 shares indirectly through an LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged trading plan. There is no inherent positive or negative implication.

Industry Context

Sales by insiders are a common occurrence and are often pre-planned through 10b5-1 trading plans to avoid accusations of trading on material non-public information. The market typically views these sales in the context of the overall holdings of the insider and the reasons behind the pre-arranged plan.

Comparison to Industry Standards

  • Comparing Schwab's insider trading activity to peers like BlackRock (BLK) or Goldman Sachs (GS) would require analyzing similar Form 4 filings for those companies.
  • Generally, insider sales are benchmarked against historical trading patterns of the individual and the company's overall insider trading activity.
  • A significant deviation from the norm could raise concerns, but routine sales under 10b5-1 plans are usually considered standard practice.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
  • However, given the pre-planned nature of the sale and the director's continued significant holdings, the overall impact is likely to be minimal.

Key Dates

DateDescription
2024-08-14Date of adoption of Rule 10b5-1 trading plan.
2025-03-06Date of stock sale transactions.
2025-03-10Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.